Softcare Limited Schedules Board Meeting for Annual Results and Dividend Decision

Softcare Limited (Stock Code: 2698), a company incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange, has issued a formal notice regarding an upcoming board meeting that could have significant implications for shareholders and investors.

Key Points from the Announcement

• Date of Board Meeting: The Board of Directors will convene on Friday, 20 March 2026.
• Purpose: The meeting will cover several important topics, including:
  • Review and approval of the audited annual results for the financial year ended 31 December 2025.
  • Publication of the annual results for public and investor access.
  • Consideration of a final dividend recommendation—the Board may decide whether or not to pay a final dividend for the year.

Details Investors Should Know

• Audited Annual Results: The release and approval of the audited annual financial statements is a highly anticipated event for investors, as it provides a comprehensive view of the company’s performance, profitability, and financial health over the past year. This information is crucial for assessing the company’s future prospects and can significantly influence share price movements.
• Dividend Decision: The Board will also deliberate on the payment of a final dividend. The announcement or withholding of a dividend can be price-sensitive news, as dividends are a direct return to shareholders. Investors should watch for the outcome of this meeting, as a positive dividend recommendation may bolster share price, whereas a decision against a dividend payment could have the opposite effect.
• Board Composition: The announcement also lists current Board members:
  • Executive Directors: Mr. Luo Jichao, Mr. Zhao Yongqiang
  • Non-executive Directors: Mr. Shen Yanchang (Chairman), Ms. Yang Yanjuan, Mr. Zhou Renwei
  • Independent Non-executive Directors: Ms. Lou Aidong, Mr. Gao Jianming, Mr. Xu Jing

  Investors should note the composition of the Board, as it reflects the governance structure and decision-making authorities within the company.

Potential Impact on Share Price

The outcome of this Board meeting is likely to be materially price-sensitive for several reasons:

• Publication of audited results could reveal either strong performance or potential weaknesses, directly affecting investor sentiment.
• The dividend recommendation is always closely watched; any change in dividend policy or amount will likely influence share valuation.

Investors are advised to monitor official communications from Softcare Limited closely around the meeting date.

Important Dates

• Board Meeting: 20 March 2026
• Annual Results Period: Year ended 31 December 2025

Disclaimer

Disclaimer: The information provided herein is based on a company announcement and is intended for informational purposes only. It does not constitute investment advice. Investors should exercise their own judgment and consult with professional advisers before making any investment decisions. The outcome of the Board meeting may materially affect Softcare Limited’s share price, but there is no guarantee of price movement. All investment involves risk.

View SOFTCARE Historical chart here